These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Mesenchymal stem cells for bone gene therapy and tissue engineering. Pelled G; G T; Aslan H; Gazit Z; Gazit D Curr Pharm Des; 2002; 8(21):1917-28. PubMed ID: 12171527 [TBL] [Abstract][Full Text] [Related]
27. Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model. Pauley P; Matthews BG; Wang L; Dyment NA; Matic I; Rowe DW; Kalajzic I Int Orthop; 2014 Sep; 38(9):1955-62. PubMed ID: 24384938 [TBL] [Abstract][Full Text] [Related]
28. Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta. Chamberlain JR; Deyle DR; Schwarze U; Wang P; Hirata RK; Li Y; Byers PH; Russell DW Mol Ther; 2008 Jan; 16(1):187-93. PubMed ID: 17955022 [TBL] [Abstract][Full Text] [Related]
30. Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs. Deyle DR; Khan IF; Ren G; Wang PR; Kho J; Schwarze U; Russell DW Mol Ther; 2012 Jan; 20(1):204-13. PubMed ID: 22031238 [TBL] [Abstract][Full Text] [Related]
31. Human endothelial colony-forming cells serve as trophic mediators for mesenchymal stem cell engraftment via paracrine signaling. Lin RZ; Moreno-Luna R; Li D; Jaminet SC; Greene AK; Melero-Martin JM Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10137-42. PubMed ID: 24982174 [TBL] [Abstract][Full Text] [Related]
32. Modification of COL1A1 in Autologous Adipose Tissue-Derived Progenitor Cells Rescues the Bone Phenotype in a Mouse Model of Osteogenesis Imperfecta. Liu Y; Wang Z; Ju M; Zhao Y; Jing Y; Li J; Shao C; Fu T; Lv Z; Li G J Bone Miner Res; 2021 Aug; 36(8):1521-1534. PubMed ID: 33950576 [TBL] [Abstract][Full Text] [Related]
33. Engraftment of skeletal progenitor cells by bone-directed transplantation improves osteogenesis imperfecta murine bone phenotype. Sinder BP; Novak S; Wee NKY; Basile M; Maye P; Matthews BG; Kalajzic I Stem Cells; 2020 Apr; 38(4):530-541. PubMed ID: 31859429 [TBL] [Abstract][Full Text] [Related]
34. Paracrine effect of mesenchymal stem cell as a novel therapeutic strategy for diabetic nephropathy. Li H; Rong P; Ma X; Nie W; Chen C; Yang C; Zhang J; Dong Q; Wang W Life Sci; 2018 Dec; 215():113-118. PubMed ID: 30399376 [TBL] [Abstract][Full Text] [Related]
35. Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds. Cantore S; Crincoli V; Boccaccio A; Uva AE; Fiorentino M; Monno G; Bollero P; Derla C; Fabiano F; Ballini A; Santacroce L Endocr Metab Immune Disord Drug Targets; 2018; 18(5):466-469. PubMed ID: 29692270 [TBL] [Abstract][Full Text] [Related]
36. Adult mesenchymal stem cells and their exosomes: Sources, characteristics, and application in regenerative medicine. Maqsood M; Kang M; Wu X; Chen J; Teng L; Qiu L Life Sci; 2020 Sep; 256():118002. PubMed ID: 32585248 [TBL] [Abstract][Full Text] [Related]
37. A Brief Overview of Global Trends in MSC-Based Cell Therapy. Jovic D; Yu Y; Wang D; Wang K; Li H; Xu F; Liu C; Liu J; Luo Y Stem Cell Rev Rep; 2022 Jun; 18(5):1525-1545. PubMed ID: 35344199 [TBL] [Abstract][Full Text] [Related]
38. Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfecta. Jones GN; Moschidou D; Lay K; Abdulrazzak H; Vanleene M; Shefelbine SJ; Polak J; de Coppi P; Fisk NM; Guillot PV Stem Cells Transl Med; 2012 Jan; 1(1):70-8. PubMed ID: 23197643 [TBL] [Abstract][Full Text] [Related]
40. Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science. Ebrahimi F; Pirouzmand F; Cosme Pecho RD; Alwan M; Yassen Mohamed M; Ali MS; Hormozi A; Hasanzadeh S; Daei N; Hajimortezayi Z; Zamani M Biotechnol Prog; 2023; 39(6):e3374. PubMed ID: 37454344 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]